contrast-induced nephropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) voluntary participation in the trial and informed consent; (2) age> 18 years; (3) planning for CAG or PCI; (4) no relevant contraindications (e. g., contrast allergy, not eligible for EECP (see the guidelines for booster therapy))
Exclusion criteria
Exclusion criteria: (1) persons allergic to contrast agents; (2) lactation or pregnancy; (3) confirmed or suspected AKI; (4) use of contrast agent or nephrotoxic drugs within 1 week prior to enrollment; (5) severe renal insufficiency requiring hemodialysis; (6) intra-aortic balloon pump, acute heart failure, liver failure, connective tissue disease, arrhythmia, tumor, serious or nosocomial infectious disease, or a history of cardiogenic shock or cardiac arrest.(7) Enhanced extracorporeal anti-bo contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| renal function;Hemorheology;hs-CRP?IL-6?TNF-a;Incidence rate of CIN; | — |
Secondary
| Measure | Time frame |
|---|---|
| ß2-MG;Urine Microprotein Series;Adverse reactions during EECP;FMD; | — |
Countries
china
Contacts
The Third Hospital of Mianyang